Cite
MLA Citation
Alberto A. Chiappori et al.. “A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.” Oncologist, vol. 21, 2016, pp. 1163–1164e. http://access.bl.uk/ark:/81055/vdc_100151234628.0x00003a